alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
### §2351. Day for taking action falling on Saturday, Sunday, or holiday

When the day, or the last day, for taking any action or paying any fee in the United States Plant Variety Protection Office falls on Saturday, Sunday, a holiday within the District of Columbia, or on any other day the Plant Variety Protection Office is closed for the receipt of papers, the action may be taken or the fee paid, on the next succeeding business day.

(Pub. L. 91–577, title I, §21, Dec. 24, 1970, 84 Stat. 1544.)
### §§156 to 161. Repealed. Pub. L. 106–224, title IV, §438(a)(1), June 20, 2000, 114 Stat. 454

Section 156, acts Aug. 20, 1912, ch. 308, §2, 37 Stat. 316; Pub. L. 100–449, title III, §301(f)(3)(B), Sept. 28, 1988, 102 Stat. 1869; Pub. L. 103–465, title IV, §431(d)(2), Dec. 8, 1994, 108 Stat. 4968, required that Secretary of Agriculture be notified of arrival of nursery stock at port of entry, prohibited forwarding without notification, and provided for inspection before shipment.

Section 157, act Aug. 20, 1912, ch. 308, §3, 37 Stat. 316, set forth marking requirements for entry of nursery stock into United States.

Section 158, act Aug. 20, 1912, ch. 308, §4, 37 Stat. 316, related to marking and inspection of imported nursery stock for interstate shipment.

Section 159, acts Aug. 20, 1912, ch. 308, §5, 37 Stat. 316; Pub. L. 97–432, §1(1), Jan. 8, 1983, 96 Stat. 2276, related to regulation of importation of plant products other than nursery stock.

Section 160, acts Aug. 20, 1912, ch. 308, §7, 37 Stat. 317; Pub. L. 97–432, §1(2), Jan. 8, 1983, 96 Stat. 2276, authorized regulations prohibiting importation of nursery stock or other plant products to prevent introduction into United States of any tree, plant or fruit disease or any injurious insect.

Section 161, acts Aug. 20, 1912, ch. 308, §8, 37 Stat. 318; Mar. 4, 1917, ch. 179, 39 Stat. 1165; Apr. 13, 1926, ch. 135, 44 Stat. 250; Pub. L. 95–439, §4, Oct. 10, 1978, 92 Stat. 1062; Pub. L. 97–432, §1(3), Jan. 8, 1983, 96 Stat. 2276; Pub. L. 104–127, title IX, §911, Apr. 4, 1996, 110 Stat. 1185, authorized quarantine of any State, territory, or district of the United States in order to prevent the spread of a dangerous plant disease or insect infestation.
IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 12-40386

Summary Calendar

UNITED STATES OF AMERICA,

Plaintiff-Appellee

v.

CARLOS ANTONIO ALVAREZ-VASQUEZ,

Defendant-Appellant

Appeal from the United States District Court

for the Southern District of Texas

USDC No. 5:09-CR-2126-1

Before BENAVIDES, HAYNES, and HIGGINSON, Circuit Judges.

PER CURIAM:*

Carlos Antonio Alvarez-Vasquez (Alvarez) appeals the 10-month prison

sentence he received following the revocation of his term of supervised release. 

Alvarez contends that the district court plainly erred when it denied him an

opportunity to allocute before his revocation sentence was imposed.

This Court must examine the basis of its jurisdiction on its own motion if

necessary. Mosley v. Cozby, 813 F.2d 659, 660 (5th Cir. 1987). Alvarez’s reply

brief was filed on October 29, 2012. Subsequently, on December 13, Alvarez was

United States Court of Appeals

Fifth Circuit

F I L E D

January 8, 2013

Lyle W. Cayce

Clerk

Pursuant to 5TH CIR. R. 47.5, the court has determined that this opinion should not *

be published and is not precedent except under the limited circumstances set forth in 5TH CIR.

R. 47.5.4.

 Case: 12-40386 Document: 00512105450 Page: 1 Date Filed: 01/08/2013
No. 12-40386

released from prison after he completed serving the instant sentence that was

imposed upon the revocation of his supervised release. Once a criminal

defendant has served his sentence, there must still be a “concrete and continuing

injury” to satisfy the case-or-controversy requirement of Article III. Spencer v.

Kemna, 523 U.S. 1, 7 (1998). Alvarez has served his sentence, and it “cannot be

undone.” Id. at 8. When the district court revoked Alvarez’s term of supervised

release, it did not impose a further term of supervised release. Thus, there are

no consequences stemming from the completed sentence that would constitute

a “concrete and continuing injury” under Article III. Id. at 7-8. This Court has

dismissed as moot appeals in which a defendant challenges an order revoking

supervised release when the defendant has served the sentence and there is no

further term of supervised release. United States v. Kline, 454 F. App’x 372 (5th

Cir. 2011); United States v. Johnson, 210 F. App’x 360 (5th Cir. 2006).1

Because the appeal has become moot, we lack appellate jurisdiction and

DISMISS the appeal. 

APPEAL DISMISSED.

The parties have notified the Court that they agree that the appeal has become moot. 1

2

 Case: 12-40386 Document: 00512105450 Page: 2 Date Filed: 01/08/2013
### §1855. Supplemental appropriations to encourage exportation and domestic consumption of agricultural products

There is hereby authorized to be appropriated for each fiscal year, beginning with the fiscal year ending June 30, 1957, the sum of $500,000,000 to enable the Secretary of Agriculture to further carry out the provisions of section 612c of this title, subject to all provisions of law relating to the expenditure of funds appropriated by such section, except that up to 50 per centum of such $500,000,000 may be devoted during any fiscal year to any one agricultural commodity or the products thereof.

(May 28, 1956, ch. 327, title II, §205, 70 Stat. 200.)
§ 776.37 Advisor. ( a ) In representing a client, a covered attorney shall exercise independent professional judgment and render candid advice. In rendering advice, a covered attorney may refer not only to law but to other considerations such as moral, economic, social, and political factors that may be relevant to the client's situation.
( b ) [Reserved]
I 

118TH CONGRESS 

2D SESSION H. R. 9773 

To amend title 38, United States Code, to eliminate copayments by the 

Department of Veterans Affairs for medicines relating to preventive 

health services, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

SEPTEMBER 24, 2024 

Ms. UNDERWOOD introduced the following bill; which was referred to the 

Committee on Veterans’ Affairs 

A BILL 

To amend title 38, United States Code, to eliminate copayments by the Department of Veterans Affairs for medicines relating to preventive health services, and for other 

purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Copay Fairness for 

5 Veterans Act’’. 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 9773 IH

1 SEC. 2. IMPROVEMENT TO PREVENTIVE HEALTH SERVICES 

2 FURNISHED BY DEPARTMENT OF VETERANS 

3 AFFAIRS. 

4 (a) ELIMINATION OF MEDICATION COPAYMENTS.— 

5 Section 1722A(a)(3) of title 38, United States Code, is 

6 amended— 

7 (1) in subparagraph (C), by striking ‘‘or’’; 

8 (2) in subparagraph (D), by striking the period 

9 at the end and inserting ‘‘; or’’; and 

10 (3) by adding at the end the following new sub11 paragraph: 

12 ‘‘(E) to medication that is or is part of a pre13 ventive health service.’’. 

14 (b) ELIMINATION OF HOSPITAL CARE AND MEDICAL

15 SERVICES COPAYMENTS.—Section 1710 of such title is 

16 amended— 

17 (1) in subsection (f)— 

18 (A) by redesignating paragraph (5) as 

19 paragraph (6); and 

20 (B) by inserting after paragraph (4) the 

21 following new paragraph (5): 

22 ‘‘(5) A veteran shall not be liable to the United States 

23 under this subsection for any amounts for preventive 

24 health services.’’; and 

25 (2) in subsection (g)(3), by adding at the end 

26 the following new subparagraph: 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
3 

•HR 9773 IH

1 ‘‘(C) Preventive health services.’’. 

2 (c) DEFINITION.—Section 1701(9) of such title is 

3 amended— 

4 (1) in subparagraph (K), by striking ‘‘; and’’ 

5 and inserting a semicolon; 

6 (2) by redesignating subparagraph (L) as sub7 paragraph (O); and 

8 (3) by inserting after subparagraph (K) the fol9 lowing new subparagraphs: 

10 ‘‘(L) evidence-based items or services that have 

11 in effect a rating of ‘A’ or ‘B’ in the current rec12 ommendations of the United States Preventive Serv13 ices Task Force; 

14 ‘‘(M) immunizations that have in effect a rec15 ommendation from the Advisory Committee on Im16 munization Practices of the Centers for Disease 

17 Control and Prevention with respect to the indi18 vidual involved; 

19 ‘‘(N) with respect to services for women— 

20 ‘‘(i) the preventive care, screenings, and 

21 contraceptives provided for in the Health Re22 sources and Services Administration Preventive 

23 Services Guidelines in effect as of December 30, 

24 2022; and 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
4 

•HR 9773 IH

1 ‘‘(ii) any contraceptive approved, granted, 

2 or cleared by the Food and Drug Administra3 tion;’’. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF THE TITAN CORPORATION'S REPORT ON FORM 10-Q FOR THE
THREE MONTHS PERIOD ENDED MARCH 31, 1998, AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<RESTATED> 
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               MAR-31-1998
<CASH>                                           1,153
<SECURITIES>                                         0
<RECEIVABLES>                                   71,028
<ALLOWANCES>                                         0<F1>
<INVENTORY>                                     19,086
<CURRENT-ASSETS>                               113,798
<PP&E>                                          59,110
<DEPRECIATION>                                  35,818
<TOTAL-ASSETS>                                 184,447
<CURRENT-LIABILITIES>                           57,040
<BONDS>                                         36,996
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                      3,695
<COMMON>                                           238
<OTHER-SE>                                      73,331
<TOTAL-LIABILITY-AND-EQUITY>                   184,447
<SALES>                                         43,916
<TOTAL-REVENUES>                                43,979
<CGS>                                           33,836
<TOTAL-COSTS>                                   33,836
<OTHER-EXPENSES>                                 8,022
<LOSS-PROVISION>                                     0<F1>
<INTEREST-EXPENSE>                               1,353
<INCOME-PRETAX>                                    903
<INCOME-TAX>                                       316
<INCOME-CONTINUING>                                587
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       587
<EPS-PRIMARY>                                      .02
<EPS-DILUTED>                                      .02
<FN>
<F1>Due to the use of condensed financial statements for interim reporting, this
information is not compiled on a quarterly basis
</FN>
        

</TABLE>
<PAGE>



                                                                    EXHIBIT 31.2


I, Don T. Scartz, certify that:


1.  I have reviewed this quarterly report on Form 10-Q of EMS Technologies,
Inc.;


2. Based on my knowledge, this report does not contain any untrue statement of
a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this report;


3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the registrant
as of, and for, the periods presented in this report;


4. The registrant's other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:


     a) Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;


     b) Evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and


     c) Disclosed in this report any change in the registrant's internal
control over financial reporting that occurred during the registrant's most
recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant's internal control over financial reporting;
and


5. The registrant's other certifying officer(s) and I have disclosed, based on
our most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent functions):


     a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and


     b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal control over
financial reporting.


By:  /s/ Don T. Scartz                                           Date: 11/11/03
     -----------------------------
     Don T. Scartz
     Executive Vice President, Chief
     Financial Officer and Treasurer
     (Principal Financial Officer)
FIRST DISTRICT COURT OF APPEAL

STATE OF FLORIDA

_____________________________

No. 1D20-0224

_____________________________

BYRON LOWERY,

Appellant,

v.

FLORIDA COMMISSION ON 

OFFENDER REVIEW,

Appellee.

_____________________________

On appeal from the Circuit Court for Gadsden County.

David Michael Frank, Judge.

September 14, 2020

PER CURIAM.

AFFIRMED.

RAY, C.J., and BILBREY and JAY, JJ., concur.

_____________________________

Not final until disposition of any timely and 

authorized motion under Fla. R. App. P. 9.330 or 

9.331.

_____________________________
2

Byron Lowery, pro se, for Appellant.

Lisa Martin, General Counsel, and Mark J. Hiers, Assistant 

General Counsel, Tallahassee, for Appellee.
<PAGE>
                                                                   EXHIBIT 10.71

                              CKE RESTAURANTS, INC.

                                 AMENDMENT NO. 2
                                       TO
                              EMPLOYMENT AGREEMENT

      This Amendment No. 2 (the "Amendment") to Employment Agreement is made
effective as of December 6, 2005, by and between CKE Restaurants, Inc. (the
"Company") and Andrew F. Puzder (the "Employee").

                                R E C I T A L S:

      A. The Company and the Employee entered into an Employment Agreement,
dated as of January 2004, as amended on February 1, 2005 (the "Agreement").

      B. The Company and Employee now desire to amend the Agreement as set forth
below.


                                    AGREEMENT

      1. Salary. Effective January 1, 2006, the minimum base annual salary shall
be $925,000.

      2. Term. Section 2 of the Agreement shall read in its entirety as follows:

            "2. Term. The term of this Agreement (the "Term") shall commence on
      the Effective Date and, subject to prior termination as set forth in
      Section 7 below, shall terminate three (3) years following the date on
      which notice of non-renewal or termination of this Agreement is given by
      either party to the other. Thus, the Term shall be renewed automatically
      on a daily basis so that the outstanding Term is always three (3) years
      following the date on which notice of non-renewal or termination is given
      by either party to the other. The Term may be extended at any time upon
      mutual written agreement of the parties."

      3. Definitions. Terms used but not defined in this Amendment shall have
the respective meanings assigned to them in the Agreement.

      4. Counterparts. This Amendment may be executed in multiple counterparts,
each of which shall be deemed an original, and all of which shall constitute one
Amendment.

      5. Terms and Conditions of Agreement. Except as specifically amended by
this Amendment, all terms and conditions of the Agreement shall remain in full
force and effect.


                            [SIGNATURE PAGE FOLLOWS]
<PAGE>
      IN WITNESS WHEREOF, this Amendment is executed by the undersigned as of
the date first written above.

                                /s/ ANDREW F. PUZDER

                                ------------------------------------------------
                                Andrew F. Puzder


                                CKE Restaurants, Inc.

                                       /s/ PETER CHURM
                                By:
                                       -----------------------------------------
                                       Peter Churm
                                       Director and Chairman of the Compensation
                                       Committee of the Board of Directors

                                       2
UNITED STATES DEPARTMENT OF EDUCATION

OFFICE OF INSPECTOR GENERAL

THE INSPECTOR GENERAL

400 MARYLAND AVENUE, S.W., WASHINGTON, DC 20202-1510

Promoting the efficiency, effectiveness, and integrity of the Department’s programs and operations.

 TO: Counsel to the Inspector General 

Assistant Counsels to the Inspector General

FROM: Sandra Bruce

Inspector General (Acting)

SUBJECT: Redelegation of Authority to Conduct and Coordinate Litigation involving Office of 

Inspector General (OIG) employees or applicants before the Equal Employment 

Opportunity Commission (EEOC), Merit Systems Protection Board (MSPB) and in 

Federal courts.

I. DELEGATION 

Under the authority vested in me by delegation EA/EF/195 from the Secretary dated September 

14, 2011, I hereby delegate to you, or to anyone serving for you in an acting capacity, the 

authority to conduct and coordinate litigation activities on personnel and equal employment 

opportunity matters which exclusively involve OIG employees or applicants to the OIG, that do 

not affect any cross-cutting or important Departmental interests as determined by you and the 

General Counsel or anyone serving in an acting capacity (consistent with the Federal Vacancies 

Reform Act) for the General Counsel or for you. This authority includes the authority to 

represent the Secretary of the U.S. Department of Education (ED) and ED before the Equal 

Employment Opportunity Commission (EEOC), the Merit Systems Protection Board (MSPB), and 

in Federal courts in complaints and/or appeals filed against ED by employees of, or applicants 

for employment within, ED’s Office of Inspector General (OIG) and settlement authority with 

respect to those cases.

Unless otherwise noted in future delegations of authority, amendments to the existing 

authorities delegated herein are included within the scope of this delegation. 

II. RESERVATIONS 

Unless otherwise noted in existing or future delegations of authority, the following is not 

delegated: Authority to provide legal advice to the Secretary on matters covered by this 

delegation of authority. 

The Counsel to the Inspector General must exercise the settlement authority with respect to 

the matters described above.

The Counsel to the Inspector General must make the determination for the OIG whether the 

litigation affects any cross-cutting or important Departmental interests.
Page 2 – Redelegation of Authority to Conduct and Coordinate Litigation

III. REDELEGATION 

No further redelegation is authorized.

IV. CERTIFICATION AND EFFECTIVE DATE 

This delegation is effective upon certification by the Department’s Principal Delegations Control 

Officer. I hereby ratify actions within the scope of this delegation taken by the addressee prior 

to the date of certification.

/s

Sandra Bruce

Date Certified: 6/3/2019

Departmental Delegations Control Officer:Jim Clemmens

Control Number: EF/EF/203
#### § 536.134 Additional claims judge advocate and claims attorney responsibilities (for UCMJ claims).

In addition to the duties set forth in this subpart, the CJA or claims attorney is responsible for forwarding copies of completed Article 139 actions to USARCS, maintaining a log, monitoring the time requirements of pending Article 139 actions, and publicizing the Article 139 program to commanders, soldiers, and the community.
<TABLE> <S> <C>


<ARTICLE>                     5
<CIK>                         0000032120
<NAME>                        Electro-Catheter Corporation
<MULTIPLIER>                  1000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>               AUG-31-1996
<PERIOD-END>                    MAY-31-1997
<CASH>                                            89
<SECURITIES>                                       0
<RECEIVABLES>                                  1,185
<ALLOWANCES>                                     (38)
<INVENTORY>                                    1,469
<CURRENT-ASSETS>                               2,944
<PP&E>                                         5,151
<DEPRECIATION>                                (4,444)
<TOTAL-ASSETS>                                 3,754
<CURRENT-LIABILITIES>                          1,244
<BONDS>                                            0
<PREFERRED-MANDATORY>                              0  
<PREFERRED>                                        0  
<COMMON>                                         638
<OTHER-SE>                                       242
<TOTAL-LIABILITY-AND-EQUITY>                   3,754  
<SALES>                                        5,138  
<TOTAL-REVENUES>                               5,138  
<CGS>                                          2,858  
<TOTAL-COSTS>                                  5,291  
<OTHER-EXPENSES>                                   0  
<LOSS-PROVISION>                                   0  
<INTEREST-EXPENSE>                              (186)
<INCOME-PRETAX>                                    0  
<INCOME-TAX>                                       0  
<INCOME-CONTINUING>                                0  
<DISCONTINUED>                                     0  
<EXTRAORDINARY>                                    0  
<CHANGES>                                          0  
<NET-INCOME>                                    (339)
<EPS-PRIMARY>                                   (.05)
<EPS-DILUTED>                                   (.05) 
        


</TABLE>